Literature DB >> 16547785

Quality of life and its relation to cancer-related stress in women of families with hereditary cancer without demonstrated mutation.

Amy Østertun Geirdal1, Lovise Maehle, Ketil Heimdal, Astrid Stormorken, Pål Møller, Alv A Dahl.   

Abstract

BACKGROUND: Although quality of life (QoL) and mental distress in women belonging to familial cancer families have been studied, little is known on these matters in women with absence of demonstrated mutations. The aim of this study was to examine QoL and cancer-related distress in such women.
METHODS: About 330 women at risk for familial cancers in the absence of demonstrated mutations were invited to the study. About 239 women (72%) (risk group) completed the Short Form 12 (SF-12) and the Impact of Event Scale (IES). The SF-12-findings were compared to the age-adjusted findings from the general female population (controls).
RESULTS: The risk group had significantly better physical QoL than controls, while no significant difference was found for mental QoL. Within the risk group the type of familial cancer did not make a significant difference in QoL, but to have a father with cancer or a deceased parent, was associated with increased risk of being a case with low QoL. Mental QoL showed moderate correlation with cancer-related distress.
CONCLUSIONS: Women belonging to familial cancer families in the absence of demonstrated mutations had at least as good QoL as controls in spite of living with a permanent cancer-related threat.

Entities:  

Mesh:

Year:  2006        PMID: 16547785     DOI: 10.1007/s11136-005-3008-3

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  36 in total

1.  Uptake of BRCA1 genetic testing in adult sisters and daughters of known mutation carriers in Norway.

Authors:  Trine Levin Bodd; Jon Reichelt; Ketil Heimdal; Pal Moller
Journal:  J Genet Couns       Date:  2003-10       Impact factor: 2.537

2.  Uptake of genetic testing and pre-test levels of mental distress in Norwegian families with known BRCA1 mutations.

Authors:  J G Reichelt; A A Dahl; K Heimdal; P Møller
Journal:  Dis Markers       Date:  1999-10       Impact factor: 3.434

3.  Variants of uncertain clinical significance as a result of BRCA1/2 testing: impact of an ambiguous breast cancer risk message.

Authors:  Sandra van Dijk; Christi J van Asperen; Catharina E Jacobi; Geraldine R Vink; Aad Tibben; Martijn H Breuning; Wilma Otten
Journal:  Genet Test       Date:  2004

4.  What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer.

Authors:  Sandra van Dijk; Wilma Otten; Daniëlle R M Timmermans; Christi J van Asperen; Hanne Meijers-Heijboer; Aad Tibben; Martijn H Breuning; Job Kievit
Journal:  Genet Med       Date:  2005-04       Impact factor: 8.822

5.  Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer.

Authors:  B Thewes; B Meiser; I B Hickie
Journal:  Psychooncology       Date:  2001 Nov-Dec       Impact factor: 3.894

6.  Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior.

Authors:  C Lerman; K Kash; M Stefanek
Journal:  J Natl Cancer Inst Monogr       Date:  1994

7.  Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy.

Authors:  Pål Møller; Ake Borg; D Gareth Evans; Neva Haites; Marta M Reis; Hans Vasen; Elaine Anderson; C Michael Steel; Jaran Apold; David Goudie; Anthony Howell; Fiona Lalloo; Lovise Maehle; Helen Gregory; Ketil Heimdal
Journal:  Int J Cancer       Date:  2002-10-20       Impact factor: 7.396

8.  Effects of individual and family functioning on interest in genetic testing.

Authors:  Deborah J Bowen; Emily Bourcier; Nancy Press; Frances M Lewis; Wylie Burke
Journal:  Community Genet       Date:  2004

9.  The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress.

Authors:  A Cull; E D Anderson; S Campbell; J Mackay; E Smyth; M Steel
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

10.  A randomized trial of specialist genetic assessment: psychological impact on women at different levels of familial breast cancer risk.

Authors:  K Brain; P Norman; J Gray; C Rogers; R Mansel; P Harper
Journal:  Br J Cancer       Date:  2002-01-21       Impact factor: 7.640

View more
  2 in total

1.  The relationship between psychological distress and personality in women from families with familial breast/ovarian or hereditary non-polyposis colorectal cancer in the absence of demonstrated mutations.

Authors:  Amy Østertun Geirdal; Alv A Dahl
Journal:  J Genet Couns       Date:  2008-07-08       Impact factor: 2.537

2.  Understanding the experience of myotonic dystrophy. Mixed method study.

Authors:  Amy Østertun Geirdal; Inger Lund-Petersen; Arvid Heiberg
Journal:  J Genet Couns       Date:  2014-08-16       Impact factor: 2.537

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.